Apigenin induces apoptosis via downregulation of S-phase kinase-associated protein 2-mediated induction of p27Kip1 in primary effusion lymphoma cells

Cell Proliferation

Volumn 43, Issue 2, 2010, Pages 170-183

  Hussain, A R ^a   Khan, A S ^a   Ahmed, S O ^a   Ahmed, M ^a   Platanias, L C ^b   Al Kuraya, K S ^a   Uddin, S ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; CASPASE 3; CASPASE 9; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYTOCHROME C; INHIBITOR OF APOPTOSIS PROTEIN; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; RETINOBLASTOMA PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2;

APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MITOCHONDRIAL MEMBRANE POTENTIAL; OLIGOMERIZATION; PRIMARY EFFUSION LYMPHOMA; PROTEIN CONFORMATION; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION;

APIGENIN; APOPTOSIS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOWN-REGULATION; HUMANS; LYMPHOMA, PRIMARY EFFUSION; S-PHASE KINASE-ASSOCIATED PROTEINS;

INTRACISTERNAL A-PARTICLES;

EID: 77649210896     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2009.00662.x     Document Type: Article

References (63)

1. Klepfish A, Sarid R, Shtalrid M, Shvidel L, Berrebi A, Schattner A (2001) Primary effusion lymphoma (PEL) in HIV-negative patients - a distinct clinical entity. Leuk. Lymphoma 41, 439 443.
2. Drexler HG, Uphoff CC, Gaidano G, Carbone A (1998) Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas). Leukemia 12, 507 517.
3. Jones KD, Aoki Y, Chang Y, Moore PS, Yarchoan R, Tosat G (1999) Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood 94, 2871 2879.
4. Masood R, Zhang Y, Bond MW, Scadden DT, Moudgil T, Law RE et al. (1995) Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. Blood 85, 3423 3430.
5. Aoki Y, Feldman GM, Tosato G (2003) Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood 101, 1535 1542.
6. Keller SA, Schattner EJ, Cesarmanm E (2000) Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 96, 2537 2542.
7. Uddin S, Hussain AR, Manogaran PS, Al-Hussein K, Platanias LC, Gutierrez MI et al. (2005) Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma. Oncogene 24, 7022 7030.
8. Prakash O, Tang ZY, Peng X, Coleman R, Gill J, Farr G et al. (2002) Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 K1 gene. J. Natl Cancer Inst. 94, 926 935.
9. Tomlinson CC, Damania B (2004) The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway. J. Virol. 78, 1918 1927. (Pubitemid 38176723)
10. Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2, 489 501.
11. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785 789.
12. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857 868.
13. Reed JC (2006) Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ. 13, 1378 1386.
14. Yang E, Korsmeyer SJ (1999) BCL-2 gene family and the regulation of programmed cell death. Cancer Res. 59, 1693 1700.
15. Zong WX, Lindsten T, Ross AJ, MacGregor GR, Thompson CB (2001) BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15, 1481 1486.
16. Mamillapalli R, Gavrilova N, Mihaylova VT, Tsvetkov LM, Wu H, Zhang H et al. (2001) PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27 (KIP1) through the ubiquitin E3 ligase SCF (SKP2). Curr. Biol. 11, 263 267.
17. Andreu EJ, Lledó E, Poch E, Ivorra C, Albero MP, Martínez-Climent JA et al. (2005) BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells. Cancer Res. 65, 3264 3272.
18. Reichert M, Saur D, Hamacher R, Schmid RM, Schneider G (2007) Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells. Cancer Res. 67, 4149 4156.
19. Nakayama KI, Nakayama K (2006) Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 6, 369 381.
20. Bloom J, Pagano M (2003) Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin. Cancer Biol. 13, 41 47.
21. Yokoi S, Yasui K, Saito-Ohara F, Koshikawa K, Iizasa T, Fujisawa T et al. (2002) A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Am. J. Pathol. 161, 207 216.
22. Kaufmann T, Tai L, Ekert PG, Huang DC, Norris F, Lindemann RK et al. (2007) The BH3-only protein bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrest. Cell 129, 423 433.
23. Dunnick JK, Hailey JR (1992) Toxicity and carcinogenicity studies of quercetin, a natural component of foods. Fundam. Appl. Toxicol. 19, 423 431.
24. Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H et al. (1997) Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res. 57, 2916 2921.
25. Yin F, Giuliano AE, Law RE, Van Herle AJ (2001) Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Anticancer Res. 21, 413 420.
26. Van Dross R, Xue Y, Knudson A, Pelling JC (2003) The chemopreventive bioflavonoid apigenin modulates signal transduction pathways in keratinocyte and colon carcinoma cell lines. J. Nutr. 133, 3800S 3804S.
27. Yin F, Giuliano AE, Van Herle AJ (1999) Growth inhibitory effects of flavonoids in human thyroid cancer cell lines. Thyroid 9, 369 376.
28. Wang IK, Lin-Shiau SY, Lin JK (1999) Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur. J. Cancer 35, 1517 1525.
29. Shukla S, Gupta S (2007) Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells. Cell Cycle 6, 1102 1114.
30. Czeczot H, Tudek B, Kusztelak J, Szymczyk T, Dobrowolska B, Glinkowska G et al. (1990) Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs. Mutat. Res. 240, 209 216.
31. Hussain AR, Al-Jomah N, Siraj AK, Manogaran P, Al-Hussein K, Abubaker J et al. (2007) Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells. Cancer Res. 67, 3888 3897.
32. Uddin S, Hussain A, Manogaran PS, Wickrema A, Gutierrez MI, Bhatia KG (2005) Inhibition of phosphatidylinositol 3′-kinase/AKT-signaling promotes apoptosis of primary effusion lymphoma cells. Clin. Cancer Res. 11, 3102 3108.
33. Hussain A, Al-Rasheed M, Manogaran PS, Al-Hussein KA, Platanias LC, Al Kuraya K et al. (2006) Curcumin induced apoptosis in acute T cell leukemias. Apoptosis 11, 245 254.
34. Uddin S, Hussain AR, Siraj AK, Manogaran PS, Al-Jomah NA, Moorji A et al. (2006) Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Blood 108, 4178 4186.
35. Uddin S, Ah-Kang J, Ulaszek J, Mahmud D, Wickrema A (2004) Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells. Proc. Natl. Acad. Sci. USA 101, 147 152.
36. Uddin S, Hussain A, Al-Hussein K, Platanias LC, Bhatia KG (2004) Inhibition of phosphatidylinositol 3′-kinase induces preferentially killing of PTEN-null T leukemias through AKT pathway. Biochem. Biophys. Res. Commun. 320, 932 938.
37. Hussain AR, Ahmed M, Al-Jomah NA, Khan AS, Manogaran P, Sultana M et al. (2008) Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines. Mol. Cancer Ther. 7, 3318 3329.
38. Assoian RK, Yung Y (2008) A reciprocal relationship between Rb and Skp2: implications for restriction point control, signal transduction to the cell cycle and cancer. Cell Cycle 7, 24 27.
39. Ji P, Jiang H, Rekhtman K, Bloom J, Ichetovkin M, Pagano M et al. (2004) An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant. Mol. Cell 16, 47 58.
40. Shapira M, Kakiashvili E, Rosenberg T, Hershko DD (2006) The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells. Breast Cancer Res. 8, R46.
41. Wang Q, Zhou Y, Wang X, Evers BM (2008) p27(Kip1) nuclear localization and cyclin-dependent kinase inhibitory activity are regulated by glycogen synthase kinase-3 in human colon cancer cells. Cell Death Differ. 15, 908 919.
42. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y et al. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231 241.
43. Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg E (2001) Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol. Cell. Biol. 21, 952 965.
44. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ (1995) Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80, 285 291.
45. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87, 619 628.
46. Downward J (1999) How BAD phosphorylation is good for survival. Nat. Cell Biol. 1, E33 E35.
47. Adhami VM, Aziz MH, Mukhtar H, Ahmad N (2003) Activation of pro-death Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratinocytes. Clin. Cancer Res. 9, 3176 3182.
48. Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S et al. (1999) Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144, 891 901.
49. de Azevedo WF Jr., Canduri F, da Silveira NJ (2002) Structural basis for inhibition of cyclin-dependent kinase 9 by flavopiridol. Biochem. Biophys. Res. Commun. 293, 566 571.
50. Shukla S, Gupta S (2005) Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft. Mol. Cancer Ther. 5, 843 852.
51. Koff A (2006) How to decrease p27Kip1 levels during tumor development. Cancer Cell 275, 1059 1065.
52. Uddin S, Ahmed M, Bavi P, El-Sayed R, Al-Sanea N, Abdul Jabbar A et al. (2008) Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer. Cancer Res. 68, 3379 3388.
53. Auld CA, Caccia CD, Morrison RF (2007) Hormonal induction of adipogenesis induces Skp2 expression through PI3 and MAPK pathways. J. Cell. Biochem. 100, 204 216.
54. Datta SR, Katsov A, Hu L, Petros A, Fesik SW, Yaffe MB et al. (2000) 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol. Cell 6, 41 51.
55. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T et al. (2001) BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell 8, 705 711.
56. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ et al. (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292, 727 730.
57. Virdee K, Parone PA, Tolkovsky AM (2000) Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival. Curr. Biol. 10, 1151 1154.
58. Tan Y, Demeter MR, Ruan H, Comb MJ (2000) BAD Ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival. J. Biol. Chem. 275, 25865 25869. (Pubitemid 30690134)
59. Zou H, Li Y, Liu X, Wang X (1999) An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274, 11549 11556.
60. Chen D, Daniel KG, Chen MS, Kuhn DJ, Landis-Piwowar KR, Dou QP (2005) Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells. Biochem. Pharmacol. 69, 1421 1432.
61. Torkin R, Lavoie JF, Kaplan DR, Yeger H (2005) Induction of caspase-dependent, p53-mediated apoptosis by Apigenin in human neuroblastoma. Mol. Cancer Ther. 4, 1 11.
62. Deveraux QL, Reed JC (1999) IAP family proteins - suppressors of apoptosis. Genes Dev. 13, 239 252.
63. Dan HC, Sun M, Kaneko S, Feldman RI, Nicosia SV, Wang HG et al. (2004) Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J. Biol. Chem. 279, 5405 5412.